Jazz Pharmaceuticals plc (NASDAQ:JAZZ) previous close was $186.42 while the outstanding shares total 56.47M. The firm has a beta of 1.04, a 12-month trailing P/E
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has a beta of 1.05, a 12-month trailing P/E ratio of 19.96, and a growth ratio of 0.69. The stock’s Relative
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has a beta of 1.04, a 12-month trailing P/E ratio of 19.29, and a growth ratio of 0.67. The stock’s Relative
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) has a beta of 1.04, a 12-month trailing P/E ratio of 19.29, and a growth ratio of 0.67. The stock’s Relative
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne
